Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0T6OQ
|
||||
Former ID |
DNC008746
|
||||
Drug Name |
3-desoxy-3-carboxamidonaltrexone
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530013] | ||
Structure |
Download2D MOL |
||||
Formula |
C21H24N2O4
|
||||
Canonical SMILES |
C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)C(=O)N)O5)O
|
||||
InChI |
1S/C21H24N2O4/c22-19(25)13-4-3-12-9-15-21(26)6-5-14(24)18-20(21,16(12)17(13)27-18)7-8-23(15)10-11-1-2-11/h3-4,11,15,18,26H,1-2,5-10H2,(H2,22,25)/t15-,18+,20+,21-/m1/s1
|
||||
InChIKey |
QAICPHMNUHNDMC-WUHBCXKYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Delta-type opioid receptor | Target Info | Inhibitor | [530013] | |
Kappa-type opioid receptor | Target Info | Inhibitor | [530013] | ||
Mu-type opioid receptor | Target Info | Inhibitor | [530013] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Opioid prodynorphin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.